Cellectar Biosciences
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -66 | |||
EBITDA | -6,400 | -12,676 | -13,259 | |
EBIT | -12,744 | -13,327 | ||
Net Income | -6,604 | -2,355 | -14,664 | -919 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,383 | -10,974 | -9,166 | -14,162 |
Cash | 13,905 | 23,288 | 34,263 | 25,868 |
Basic Shares | 46,079 | 46,079 | 39,794 | 35,848 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -192 | -192 | -238 | -227 |
EBITDA | -44,223 | -38,768 | -28,665 | -23,981 |
EBIT | -44,515 | -38,960 | -28,813 | -24,131 |
Net Income | -44,581 | -37,983 | -28,601 | -23,970 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -47,687 | -33,241 | -25,448 | -22,710 |
Cash | 23,288 | 9,564 | 19,866 | 35,703 |
Basic Shares | 37,143 | 12,221 | 7,055 | 5,551 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$3.39 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.01 |
2024-09-30 | -$0.37 |
